For the quarter ending 2026-03-31, KYMR has $1,669,016K in assets. $129,379K in debts. $144,090K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Contract assets | - | - | 0 | 0 |
| Cash and cash equivalents | 144,090 | 357,011 | 112,949 | 335,816 |
| Marketable securities (note 4) | 506,839 | 491,265 | 392,733 | 329,629 |
| Accounts receivable | - | - | - | 40,000 |
| Prepaid expenses and other current assets | 26,503 | 22,938 | 22,616 | 22,882 |
| Total current assets | 677,432 | 871,214 | 528,298 | 728,327 |
| Marketable securities, non-current (note 4) | 894,724 | 771,158 | 473,055 | 297,629 |
| Total property and equipment | 65,674 | - | 67,483 | - |
| Less accumulated depreciation | 24,057 | - | 22,355 | - |
| Property and equipment, net (note 6) | 41,617 | 43,175 | 45,128 | 48,572 |
| Right-of-use assets, operating leases | 41,736 | 42,351 | 42,947 | 46,045 |
| Other non-current assets | 7,697 | 9,114 | 6,828 | 4,675 |
| Restricted cash | 5,810 | 5,800 | 5,788 | 5,820 |
| Total assets | 1,669,016 | 1,742,812 | 1,102,044 | 1,131,068 |
| Accounts payable | 12,839 | 4,015 | 5,506 | 5,781 |
| Accrued expenses (note 8) | 35,095 | 42,274 | 28,639 | 27,976 |
| Deferred revenue | 0 | 22,925 | 23,279 | 40,000 |
| Operating lease liabilities | 12,032 | 11,941 | 11,853 | 11,766 |
| Finance lease liabilities | 1,701 | 1,815 | 1,890 | 1,900 |
| Other current liabilities | 976 | 242 | 408 | 117 |
| Total current liabilities | 62,643 | 83,212 | 71,575 | 87,540 |
| Deferred revenue, net of current portion | 0 | 11,440 | 13,957 | - |
| Operating lease liabilities, net of current portion | 65,585 | 67,034 | 68,450 | 69,835 |
| Finance lease liabilities, net of current portion | 1,151 | 1,462 | 1,804 | 2,213 |
| Total liabilities | 129,379 | 163,148 | 155,786 | 159,588 |
| Common stock, 0.0001 par value 150,000,000 shares authorized at march 31, 2026 and december 31, 2025, 82,182,101 and 81,323,532 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 8 | 8 | 7 | 7 |
| Additional paid-in capital | 2,679,018 | 2,643,817 | 1,923,730 | 1,867,999 |
| Accumulated deficit | -1,135,195 | -1,065,961 | -978,980 | -896,805 |
| Accumulated other comprehensive loss | -4,194 | 1,800 | 1,501 | 279 |
| Total stockholders equity | 1,539,637 | 1,579,664 | 946,258 | 971,480 |
| Total liabilities and stockholders equity | 1,669,016 | 1,742,812 | 1,102,044 | 1,131,068 |
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)